Tuberculosis remains one of the major causes of global death from a single infectious agent.
This situation is worsened by the HIV/AIDS pandemic because one-third of HIV/AIDS …

Background Smear-negative pulmonary tuberculosis (SN-PTB), which is common in HIV-
infected patients, is difficult to diagnose using smear microscopy alone. In 2007, the WHO …

Recently, the need for rapid, reliable, and low-cost drug susceptibility testing (DST) methods
has increased due to the emergence of multidrug-resistant Mycobacterium tuberculosis …

Background The case fatality rate in patients with tuberculosis (TB) associated with human
immunodeficiency virus (HIV) has been particularly high in Chiang Rai, Northern Thailand. It …

Abstract Background Microscopic Observation Drug Susceptibility (MODS) and Xpert
MTB/Rif (Xpert) are highly sensitive tests for diagnosis of pulmonary tuberculosis (PTB). This …

Tuberculosis (TB) and human immunodeficiency virus (HIV) co-epidemics form a huge
burden of disease in the Southeast Asia region. Five out of eleven nations in this region are …

Background: The converging epidemics of HIV and tuberculosis (TB) pose one of the
greatest public health challenges of our time. Rapid diagnosis of TB is essential in view of its …

Several rapid non-commercial culture-based methods and assays for drug susceptibility
testing (DST) of Mycobacterium tuberculosis have emerged over the last decades. The aim …

Nanotechnology has proved to be a promising tool for the whole scientific community by
creating new and superior therapeutic ways for advanced treatment of various diseases. In …

Inexpensive, rapid, and reliable tests for detecting the presence and drug susceptibility of
Mycobacterium tuberculosis complex (MTBC) are urgently needed to control the …